Myriad Genetics (MYGN) Gains from Investment Securities (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Gains from Investment Securities of $100000.0 for Q1 2026, up 120.0% YoY from $45454.5 in Q1 2025, and down 91.67% sequentially from $1.2 million in Q4 2025.
Myriad Genetics (MYGN) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Myriad Genetics has disclosed Gains from Investment Securities across 18 years of filings, most recently posting $100000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 120.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $7.9 million (up 1416.67% YoY), while the FY2025 annual figure was $7.3 million, changed N/A from the prior year.
- Gains from Investment Securities retreated to $100000.0 in Q1 2026, from $1.2 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for MYGN reached as high as $12.0 million in Q3 2024 and fell as low as -$12.2 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is $200000.0 (2022), against an average of $400000.0.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities tumbled 1425.0% — and 2025, when it jumped 600.0%.
- A 5-year view of Gains from Investment Securities shows it stood at -$9.1 million in 2022, then soared by 91.21% to -$800000.0 in 2023, then plunged by 1425.0% to -$12.2 million in 2024, then jumped by 109.84% to $1.2 million in 2025, then slumped by 91.67% to $100000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $100000.0, $1.2 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.20 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | -12.20 Mn |
| Dec 31, 2024 | -12.20 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -800,000.00 |
| Dec 31, 2023 | -800,000.00 |